Acubens' mission is to develop and commercialise medical devices for rapid diagnostic on the field.
To this end, Acubens relies on a portfolio of patents and technological and biological innovations resulting from our collaboration with the CEA.
As early as 2018, DosiKit will be made available to emergency medical forces and civilian authorities, enabling the measurement of individual irradiation in crisis, accidental or malicious situations.
But beyond the biodosimetry of irradiation, the remarkable versatility of the Fab-zipper technology makes it possible to envisage different applications in the area of protein engineering and service the entire antibody market.
Acubens was created in 2014 by young doctors from the CEA together with experienced managers and experienced researchers. All of them wanted to gather their skills and their areas of expertise in order to promote these innovations and respond to medical situations that had remained unresolved. They have been working together since, to progress research, product development and marketing.